Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00352092 · ClinicalTrials.gov registry record · Phase 4
Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
A Phase 4 study of Renal Transplant, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00352092: Completed Phase 4 study of Renal Transplant, sponsored by University of Cincinnati.
NCT00352092 is a Phase 4 study of Renal Transplant that has completed, run by University of Cincinnati. The registered enrollment target is 20 participants, below the 48-participant average among 5 other Renal Transplant trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00352092, a Phase 4 study of Renal Transplant, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of a steroid-free and calcineurin-inhibitor free treatment regimen for patients who are receiving a kidney transplant from a living donor that is HLA-identical (has a similar immune system).
Conditions Studied
Interventions
- DRUG sirolimus
- DRUG mycophenolate mofetil
- DRUG calcineurin inhibitor
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2002-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
What the finished NCT00352092 record still lists
NCT00352092 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 48-participant average among 5 other Renal Transplant trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Renal Transplant appearing as the primary indexed condition, and to 3 interventions - of which sirolimus is the first listed.
NCT00352092 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00352092 about?
NCT00352092 is a clinical study titled "Pilot Study for HLA Identical Living Donor Renal Transplant Recipients". The purpose of this study is to evaluate the safety and effectiveness of a steroid-free and calcineurin-inhibitor free treatment regimen for patients who are receiving a kidney transplant from a living donor that is HLA-identical (has a similar immune system).
What is the current status of trial NCT00352092?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2002-06. Estimated completion is 2007-12.
What conditions does trial NCT00352092 study?
This clinical trial studies the following conditions: Renal Transplant.
What interventions are being tested in trial NCT00352092?
The interventions under investigation include: sirolimus (DRUG), mycophenolate mofetil (DRUG), calcineurin inhibitor (DRUG).
Who is sponsoring clinical trial NCT00352092?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00352092 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cognitive Outcomes in Stable Renal Transplant Patients Switched FromTacrolimus to Envarsus XR™
ACTIVE NOT RECRUITING · Phase 4
-
Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN
ACTIVE NOT RECRUITING · Phase 2
-
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
COMPLETED
-
"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"
COMPLETED · Phase 2
-
The Use of ACE Inhibitors in the Early Renal Post-transplant Period
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia